Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects
Clinical trial NCT00546871 · COMPLETED
Trial details
- NCT number
- NCT00546871
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-03
- Primary completion
- 2009-07-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.